Cargando…
RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
Lung cancers are the leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) being the most aggressive type. At the time of diagnosis, SCLC has usually already metastasized, and an astonishing 95% of patients eventually succumb to the disease. This highlights the need fo...
Autores principales: | Loiselle, Julie J., Roy, Justin G., Sutherland, Leslie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491171/ https://www.ncbi.nlm.nih.gov/pubmed/28662214 http://dx.doi.org/10.1371/journal.pone.0180258 |
Ejemplares similares
-
RBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways
por: Loiselle, Julie J., et al.
Publicado: (2016) -
RBM10: Harmful or helpful‐many factors to consider
por: Loiselle, Julie J., et al.
Publicado: (2018) -
RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours
por: Wang, Ke, et al.
Publicado: (2007) -
Post-transcriptional regulation of Rbm5 expression in undifferentiated H9c2 myoblasts
por: Loiselle, Julie J., et al.
Publicado: (2015) -
Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site
por: Tessier, Sarah J, et al.
Publicado: (2015)